Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0001662252-17-000121
Filing Date
2017-06-15
Accepted
2017-06-15 17:04:13
Documents
2
Period of Report
2016-11-01

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT form3a.html 3/A  
1 OWNERSHIP DOCUMENT form3a.xml 3/A 6595
2 EX-24 poa.htm EX-24 7900
  Complete submission text file 0001662252-17-000121.txt   16043
Mailing Address 99 HAYDEN AVENUE, SUITE 230 LEXINGTON MA 02421
Business Address 99 HAYDEN AVENUE, SUITE 230 LEXINGTON MA 02421 781-778-7720
Xenetic Biosciences, Inc. (Issuer) CIK: 0001534525 (see all company filings)

EIN.: 452952962 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 99 HAYDEN AVENUE, SUITE 230 LEXINGTON MA 02421
Business Address
Maguire Michael Scott (Reporting) CIK: 0001690490 (see all company filings)

Type: 3/A | Act: 34 | File No.: 001-37937 | Film No.: 17914102